Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection
NCT06620627 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000
Last updated 2025-01-29
Summary
The PROCEED-CRC study will prospectively collect blood samples from participants who are at average risk of colorectal cancer (CRC). Samples will be used for research use and the development of a blood-based CRC screening test.
Conditions
- Colorectal Cancer Screening
Sponsors & Collaborators
-
Natera, Inc.
lead INDUSTRY
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-01-26
- Primary Completion
- 2025-07-31
- Completion
- 2025-10-31
Countries
- United States
Study Locations
More Related Trials
-
Development and Validation of a Blood Test for Early Diagnosis of Colorectal Cancer
NCT06889883 ·Status: RECRUITING
-
SMARTER: Using Blood Samples to iMprove FIT-bAsed coloRecTal cancEr scReening
NCT06714318 ·Status: RECRUITING
-
Personalized Screening Plans to Increase Colorectal Cancer Screening in Healthy Participants
NCT00617071 ·Status: UNKNOWN ·Phase: PHASE3
-
Screening Tests in Detecting Colorectal Cancer
NCT00025025 ·Status: COMPLETED
-
Plasma-based Colorectal Cancer Screening Research & Development
NCT04027790 ·Status: COMPLETED
-
Smart Measurement of Circulating Tumor DNA
NCT06989814 ·Status: RECRUITING ·Phase: NA
-
Collection of Samples From the United States Population for Optimization and Evaluation of Colorectal Cancer (CRC) Plasma Circulating Free-DNA (cfDNA) Marker Panel Performance
NCT07310446 ·Status: RECRUITING
-
Simultaneous Improvement in Colon Cancer Screening Rates and Patient-Centered Care
NCT02377232 ·Status: COMPLETED ·Phase: NA
-
Tumoral Circulating Cells and Colorectal Cancer Progression
NCT03256084 ·Status: UNKNOWN ·Phase: NA
-
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
NCT02503631 ·Status: TERMINATED
-
Colorectal Cancer Screening Intervention for Family Members of Colorectal Cancer Patients
NCT00582829 ·Status: COMPLETED
-
Screening With a DNA Blood Test to Address Colorectal Cancer Inequities
NCT06929481 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Blood Collection Sub-Study for CRC Screening in Individuals 45-49 at Average Risk for CRC.
NCT03741166 ·Status: COMPLETED
-
Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients
NCT00899626 ·Status: RECRUITING
-
Evaluation of PreveCol's Efficiency As a Second Line Method for the Early Colorectal Cancer Detection
NCT06703632 ·Status: RECRUITING ·Phase: NA
-
Assessment of Clinically Related Outcomes and Biomarker Analysis for Translational Integration in Colorectal Cancer
NCT01762813 ·Status: RECRUITING
-
Molecular Basis for Variations in Hereditary Colorectal Cancer Syndromes
NCT02863172 ·Status: RECRUITING
-
High Definition Single Cell Analysis in Colorectal Cancer
NCT02809716 ·Status: COMPLETED
-
GI SPORE Colon Biosample Protocol
NCT02243267 ·Status: COMPLETED
-
Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction
NCT06096688 ·Status: RECRUITING
-
Collection of Blood, Urine, and Stool to Monitor MetastaticColorectal Cancers
NCT03563651 ·Status: COMPLETED
-
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: "Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C"
NCT04144751 ·Status: COMPLETED
-
New bioMarkers tO straTIfy cOlorectal caNcer Referrals
NCT07035691 ·Status: RECRUITING
-
Colorectal Cancer Screening Validation Study
NCT00720993 ·Status: UNKNOWN
-
Colonoscopy or Fecal Occult Blood Test in Screening Healthy Participants for Colorectal Cancer
NCT00102011 ·Status: COMPLETED ·Phase: PHASE3